TY  - CHAP
A1  - Schwaneck, Stefan
A1  - Welge, Christopher
A1  - Bopp, Ann-Kathrin
A1  - Faulhaber, Sarah
A1  - Hampel, Susanne
A1  - Pfletschinger, Maike
A1  - Nebelung, Lisa
A1  - Hamme, Berit
A1  - Priddat, Birger
A1  - Salmen, Thomas
A1  - Rosenthal, Georg
A1  - Neumann, Bernd
A1  - Deeg, Steffen
A1  - Buytendijk, Frank
A1  - Gonzalez, Thomas
A1  - Träger, Gloria
A1  - Mayer, Benjamin
A1  - Mohamad, Christoph
A1  - Reinders, Heinz
A1  - Bohmeier, Bernhard
T1  - Chef, lass uns mal Kultur machen! Festschrift zum 6. Würzburger Wirtschaftssymposium
N2  - Am Montag, den 29. November 2010 fand das 6. Würzburger Wirtschaftssymposium unter dem Leitmotiv "Chef, lass uns mal Kultur machen!" statt. Die gemeinnützige Veranstaltung versteht sich seit jeher als Ort der Begegnung und des gemeinsamen Gedankenaustauschs, Studenten und Mitarbeiter aller Fachbereiche nahmen ebenso teil wie interessierte Bürger außerhalb der Würzburger Hochschulen. Die Festschrift enthält Interviews mit sowie Gastbeiträge von Referenten des 6. Würzburger Wirtschaftssymposiums. Darüber hinaus greifen Gastbeiträge von Experten aus Wissenschaft, Wirtschaft, Politik und Gesellschaft weitere Facetten auf und stellen das Thema damit auf eine breitere Grundlage.
KW  - Festschrift
KW  - Unternehmenskultur
KW  - Kulturwirtschaft
KW  - Geistiges Eigentum
KW  - Jugendkultur
KW  - Wirtschaft
KW  - Kultur
KW  - Unternehmenskultur
KW  - Kreativ- und Kulturwirtschaft
KW  - Mainfranken Theater
KW  - business culture
KW  - economics
KW  - intellectual property
Y1  - 2010
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-53329
SN  - 978-3-923959-66-2
ER  - 
TY  - JOUR
A1  - Meier, Johannes P.
A1  - Möbus, Selina
A1  - Heigl, Florian
A1  - Asbach-Nitzsche, Alexandra
A1  - Niller, Hans Helmut
A1  - Plentz, Annelie
A1  - Avsar, Korkut
A1  - Heiß-Neumann, Marion
A1  - Schaaf, Bernhard
A1  - Cassens, Uwe
A1  - Seese, Bernd
A1  - Teschner, Daniel
A1  - Handzhiev, Sabin
A1  - Graf, Uwe
A1  - Lübbert, Christoph
A1  - Steinmaurer, Monika
A1  - Kontogianni, Konstantina
A1  - Berg, Christoph
A1  - Maieron, Andreas
A1  - Blaas, Stefan H.
A1  - Wagner, Ralf
A1  - Deml, Ludwig
A1  - Barabas, Sascha
T1  - Performance of T-Track\(^®\) TB, a novel dual marker RT-qPCR-based whole-blood test for improved detection of active tuberculosis
JF  - Diagnostics
N2  - Tuberculosis (TB) is one of the leading causes of death by an infectious disease. It remains a major health burden worldwide, in part due to misdiagnosis. Therefore, improved diagnostic tests allowing the faster and more reliable diagnosis of patients with active TB are urgently needed. This prospective study examined the performance of the new molecular whole-blood test T-Track\(^®\) TB, which relies on the combined evaluation of IFNG and CXCL10 mRNA levels, and compared it to that of the QuantiFERON\(^®\)-TB Gold Plus (QFT-Plus) enzyme-linked immunosorbent assay (ELISA). Diagnostic accuracy and agreement analyses were conducted on the whole blood of 181 active TB patients and 163 non-TB controls. T-Track\(^®\) TB presented sensitivity of 94.9% and specificity of 93.8% for the detection of active TB vs. non-TB controls. In comparison, the QFT-Plus ELISA showed sensitivity of 84.3%. The sensitivity of T-Track\(^®\) TB was significantly higher (p < 0.001) than that of QFT-Plus. The overall agreement of T-Track\(^®\) TB with QFT-Plus to diagnose active TB was 87.9%. Out of 21 samples with discordant results, 19 were correctly classified by T-Track\(^®\) TB while misclassified by QFT-Plus (T-Track\(^®\) TB-positive/QFT-Plus-negative), and two samples were misclassified by T-Track\(^®\) TB while correctly classified by QFT-Plus (T-Track\(^®\) TB-negative/QFT-Plus-positive). Our results demonstrate the excellent performance of the T-Track\(^®\) TB molecular assay and its suitability to accurately detect TB infection and discriminate active TB patients from non-infected controls.
KW  - tuberculosis
KW  - TB
KW  - active TB
KW  - infection detection
KW  - T-Track\(^®\) TB
KW  - QuantiFERON\(^®\)-TB Gold Plus
KW  - mRNA
KW  - RT-qPCR
KW  - CXCL10
KW  - IFNG
Y1  - 2023
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-304113
SN  - 2075-4418
VL  - 13
IS  - 4
ER  - 
TY  - JOUR
A1  - Schmidbauer, Moritz L.
A1  - Ferse, Caroline
A1  - Salih, Farid
A1  - Klingner, Carsten
A1  - Musleh, Rita
A1  - Kunst, Stefan
A1  - Wittstock, Matthias
A1  - Neumann, Bernhard
A1  - Schebesch, Karl-Michael
A1  - Bösel, Julian
A1  - Godau, Jana
A1  - Lochner, Piergiorgio
A1  - Adam, Elisabeth H.
A1  - Jahnke, Kolja
A1  - Knier, Benjamin
A1  - Schirotzek, Ingo
A1  - Müllges, Wolfgang
A1  - Notz, Quirin
A1  - Dengl, Markus
A1  - Güldner, Andreas
A1  - Onur, Oezguer A.
A1  - Garcia Borrega, Jorge
A1  - Dimitriadis, Konstantinos
A1  - Günther, Albrecht
T1  - COVID-19 and intracranial hemorrhage: a multicenter case series, systematic review and pooled analysis
JF  - Journal of Clinical Medicine
N2  - Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) profoundly impacts hemostasis and microvasculature. In the light of the dilemma between thromboembolic and hemorrhagic complications, in the present paper, we systematically investigate the prevalence, mortality, radiological subtypes, and clinical characteristics of intracranial hemorrhage (ICH) in coronavirus disease (COVID-19) patients. Methods: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we performed a systematic review of the literature by screening the PubMed database and included patients diagnosed with COVID-19 and concomitant ICH. We performed a pooled analysis, including a prospectively collected cohort of critically ill COVID-19 patients with ICH, as part of the PANDEMIC registry (Pooled Analysis of Neurologic Disorders Manifesting in Intensive Care of COVID-19). Results: Our literature review revealed a total of 217 citations. After the selection process, 79 studies and a total of 477 patients were included. The median age was 58.8 years. A total of 23.3% of patients experienced the critical stage of COVID-19, 62.7% of patients were on anticoagulation and 27.5% of the patients received ECMO. The prevalence of ICH was at 0.85% and the mortality at 52.18%, respectively. Conclusion: ICH in COVID-19 patients is rare, but it has a very poor prognosis. Different subtypes of ICH seen in COVID-19, support the assumption of heterogeneous and multifaceted pathomechanisms contributing to ICH in COVID-19. Further clinical and pathophysiological investigations are warranted to resolve the conflict between thromboembolic and hemorrhagic complications in the future.
KW  - COVID-19
KW  - intracranial hemorrhage
KW  - prognosis
KW  - anticoagulation
Y1  - 2022
U6  - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-255236
SN  - 2077-0383
VL  - 11
IS  - 3
ER  -